Our study's insights into BCAS3 expression correlations with clinicopathological features and patient prognosis highlight its possible involvement in tumor aggressiveness and complex interactions between viral factors and tumor development in HPV-positive and HPV-negative HNSCC. Here, BCAS3 is linked to neoplasm.